Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-06-13
2006-06-13
Kim, Vickie (Department: 1618)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S312000, C424S641000
Reexamination Certificate
active
07060696
ABSTRACT:
A chelation complex including 8-hydroxyquinoline and zinc mixed with a carrier demonstrates therapeutic efficacy in treating lesions including cancerous lesions, precancerous lesions, cysts and warts.
REFERENCES:
patent: 4868172 (1989-09-01), Sebestyen et al.
patent: 5536502 (1996-07-01), Mulder
patent: 5817675 (1998-10-01), Whitefield
patent: 6124374 (2000-09-01), Kolias et al.
patent: 0 506 207 (1992-09-01), None
patent: 506207 (1992-09-01), None
patent: 0506207 (1992-09-01), None
patent: 2 189 144 (1987-04-01), None
Merck Index, 12thedition, 1996, p. 832, paragraph 4890, see 8-hydroxyquinoline.
XP-002108240 Anti-proliferative Effects and Phenotypic Alterations Induced by 8-hydroxyquinoline in Melanoma Cell Lines, by Jardena Nordenberg, Abraham Novogrodsky, Einat Beery, Miriam Patia, Lina Wasserman and Abraham Warshawsky, 1990.
Hanson Carl C.
Jordan Russel T.
Potestio Frank S.
Dermex Pharmaceuticals, LLC
Kim Vickie
Lathrop & Gage L.C.
LandOfFree
Chelated 8-hydroxyquinoline and use thereof in a method of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Chelated 8-hydroxyquinoline and use thereof in a method of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chelated 8-hydroxyquinoline and use thereof in a method of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3673704